New Poll Shows Widespread Support for Psilocybin Research & Rescheduling in UK

Psilocybin Alpha reports

A poll conducted by Drug Science and Psilonautica, in collaboration with YouGov, has found that a majority of Brits support further research into psilocybin.

Among other questions, the poll asked:

To what extent would you support or oppose the government relaxing restrictions on research into the medical use of magic mushroom-based treatments (psilocybin- assisted therapies) for mental health conditions if this didn’t affect how it was classified in criminal law (e.g. as a class A drug)?

The infographic below depicts support across geographies and political leanings, with only 13% of respondents in opposition.

In an Op-ed for Psilocybin Alpha, British MP Crispin Blunt, who launched the Conservative Drug Policy Reform Group, discusses this apparent mismatch between the public’s perception of psilocybin-assisted psychotherapy and the Home Office’s policies.

Nevertheless, 58% support law changes to permit terminally ill patients to access it with therapy—a demographic for which it is already clinically evidenced to offer otherwise-unattainable solace and peace-of-mind. Tellingly, this rose to 68% with education on clinical research and similar policy advances elsewhere in the world, and opposition shrank to just 9% – the remaining proportion just not having enough information to make a decision.

The results of Psilonautica’s population sampling with DrugScience say more about the compassion and discernment of the British public than they do about psilocybin.

Read the full piece here.

Primary Sponsor

Top Marijuana Blog